Accelerating Access through Strengthening Regulatory Harmonization of Medical Products and Health Innovations in Africa
Organised by PATH
As African countries advance plans for achieving UHC, there is widespread recognition that we will not reach our goals without innovation of all kinds. In particular, the need for research and development to advance new tools to deliver quality, affordable healthcare is highlighted prominently in both the Astana Declaration on Primary Health Care and the SDG 3 Action Plan. With this session, PATH aims to delve into “how” we will drive innovation for UHC. Specifically, taking maternal, newborn, and child health as an example, the session will explore what factors are needed to advance new health innovations—including products and system innovations—to ensure they are scaled up and access is achieved for all populations. The session will strive to link the close relation that exists between the time it takes to regulate lifesaving products and the actual lives saved as well as the impact of such regulatory harmonization to the socio-economic development in Africa. A panel of stakeholders will discuss funding needs, improvements to regulatory systems to get products approved quickly while ensuring quality, data for decision making, and advocacy to hold decision makers accountable.